abstract |
Described are methods for treating or preventing cancer in a subject by administering a vaccine, an inhibitor of idoleamine 2, 3-dioxygenase to the subject. The vaccine may comprise and allogenic PDA tumor cell engineered to secrete granulocyte macrophages colony-stimulating factor (GM-CSF). |